Takeda Sues Dr. Reddy's Over Generic Actos
Takeda lodged its complaint Thursday in the U.S. District Court for the Southern District of New York, in a continued effort to keep generic Actos off the market.
Osaka, Japan-based Takeda filed the suit after learning that Dr. Reddy’s had filed an abbreviated new drug application to market generic Actos, also known as pioglitazone hydrochloride tablets.
Actos is used in addition...
To view the full article, register now.